- Trials with a EudraCT protocol (4,668)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4,668 result(s) found.
Displaying page 1 of 234.
EudraCT Number: 2008-006649-18 | Sponsor Protocol Number: 08/0214 | Start Date*: 2011-11-16 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: CMV TCR Gene Therapy: A Phase I Safety, Toxicity and Feasibility Study of Adoptive Immunotherapy with CMV TCR-transduced Donor-derived T cells for Recipients of Allogeneic Haematopoietic Stem Cell ... | |||||||||||||
Medical condition: CMV reactivation/infection in post allogeneic haematopoietic stem cell transplant recipients. Allo-HSCT being performed for underlying haematological malignancy (eg, AML, ALL, NHL, Hodgkin Lymphoma... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023062-40 | Sponsor Protocol Number: PRP-001 | Start Date*: 2011-04-19 | |||||||||||
Sponsor Name:Medivation, Inc. | |||||||||||||
Full Title: A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered Talazoparib (BMN 673) in Patients with Advanced or Recurrent Solid Tumors | |||||||||||||
Medical condition: Advanced or recurrent solid tumors for which there is no accepted standard treatment or for which standard treatment has failed. Patients may also be eligible if they are unable or decline to unde... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005066-38 | Sponsor Protocol Number: CINC424AGB02 | Start Date*: 2012-03-09 |
Sponsor Name:Novartis Pharmaceuticals UK Ltd | ||
Full Title: A UK open-label, multicentre, exploratory Phase II study of INC424 for patients with primary myelofibrosis (PMF) or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelof... | ||
Medical condition: primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (PPV MF) or Post essential thrombocythemia myelofibrosis (PET-MF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002786-35 | Sponsor Protocol Number: 12/0246 | Start Date*: 2012-11-05 | |||||||||||
Sponsor Name:University College London | |||||||||||||
Full Title: A randomised double-blind controlled phase III study to compare the efficacy and safety of intravenous ferric carboxymaltose with placebo in patients with anaemia undergoing major open abdominal su... | |||||||||||||
Medical condition: Anaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005629-65 | Sponsor Protocol Number: RG_12-269 | Start Date*: 2014-01-15 | |||||||||||
Sponsor Name:University of Birmingham | |||||||||||||
Full Title: Management of Transformed Chronic myeloid leukaemia: Ponatinib and Intensive chemotherapy: a dose finding study | |||||||||||||
Medical condition: Chronic Myeloid Leukaemia (CML) in Blast Phase | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005279-18 | Sponsor Protocol Number: RG_11-164 | Start Date*: 2012-02-08 | ||||||||||||||||
Sponsor Name:University of Birmingham | ||||||||||||||||||
Full Title: A RandoMised study of best Available therapy versus JAK Inhibition in patients with high risk Polycythaemia Vera or Essential Thrombocythaemia who are resistant or intolerant to HydroxyCarbamide. | ||||||||||||||||||
Medical condition: Polycythaemia vera Essential Thrombocythaemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003785-14 | Sponsor Protocol Number: 200249 | Start Date*: 2014-03-03 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and MK-3475 in Subjects with Advanced Renal Cell Carcinoma | ||||||||||||||||||
Medical condition: Renal Cell Carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-002505-62 | Sponsor Protocol Number: STH16404 | Start Date*: 2013-11-14 | |||||||||||
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | |||||||||||||
Full Title: SarCaBon: A randomised phase II trial of Saracatinib versus placebo for cancer-induced bone pain | |||||||||||||
Medical condition: Cancer-induced bone pain | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003488-71 | Sponsor Protocol Number: OVG-2013/04 | Start Date*: 2013-12-12 |
Sponsor Name:University of Oxford | ||
Full Title: A pilot study of the impact of BCG administration on the immunogenicity of serogroup C meningococcal conjugate vaccine in healthy infants | ||
Medical condition: Vaccine responses | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003025-10 | Sponsor Protocol Number: VIVID | Start Date*: 2011-11-08 | |||||||||||||||||||||
Sponsor Name:King's College London [...] | |||||||||||||||||||||||
Full Title: Effect of active vitamin-D treatment on left ventricular hypertrophy in patients with type-2 diabetes and stage-3 chronic kidney disease. | |||||||||||||||||||||||
Medical condition: Left ventricular hypertrophy, type 2 diabetes, chronic kidney disease. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020841-29 | Sponsor Protocol Number: ADAPT | Start Date*: 2011-07-07 | ||||||||||||||||
Sponsor Name:King`s College London [...] | ||||||||||||||||||
Full Title: The role of anti-IgE (omalizumab) in the management of severe recalcitrant paediatric atopic eczema | ||||||||||||||||||
Medical condition: Severe eczema in children | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000919-22 | Sponsor Protocol Number: OMB114578 | Start Date*: 2011-09-14 | |||||||||||
Sponsor Name:University of Liverpool [...] | |||||||||||||
Full Title: RIAltO: A Randomised Investigation of Alternative Ofatumumab-containing regimens in less fit patients with CLL | |||||||||||||
Medical condition: Chronic Lymphocytic Leukaemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-003254-90 | Sponsor Protocol Number: CLFG316A2204 | Start Date*: 2012-05-14 | ||||||||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||||||||||||
Full Title: A randomised, active-controlled, open-label, multiple-dose, proof-of-concept study of intravitreal LFG316 in patients with active non-infectious intermediate-, posterior-, or panuveitis requiring s... | ||||||||||||||||||||||||||||
Medical condition: Active non-infectious intermediate-, posterior-, or panuveitis requiring systemic immunosuppressive therapy | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003301-26 | Sponsor Protocol Number: IAFIPF001 | Start Date*: 2013-09-20 | |||||||||||
Sponsor Name:Newcastle Upon Tyne Hospitals NHS Foundation Trust | |||||||||||||
Full Title: A randomised placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis (IPF) | |||||||||||||
Medical condition: Idiopathic Pulmonary Fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004909-33 | Sponsor Protocol Number: LCTU122 | Start Date*: 2015-09-21 | ||||||||||||||||
Sponsor Name:Manchester University NHS Foundation Trust | ||||||||||||||||||
Full Title: Thrombin Inhibition Preoperatively in Early Breast Cancer | ||||||||||||||||||
Medical condition: Breast Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000376-26 | Sponsor Protocol Number: ZPL521/101 | Start Date*: 2016-05-09 | |||||||||||
Sponsor Name:Ziarco Pharma Ltd | |||||||||||||
Full Title: A Randomised, Adaptive Design, Double-Blind (3rd Party Open), Placebo Controlled, Sequential Group Study to Determine the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Applica... | |||||||||||||
Medical condition: Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003198-14 | Sponsor Protocol Number: VP-VEC-162-3106 | Start Date*: 2015-12-21 | |||||||||||
Sponsor Name:Vanda Pharmaceuticals Inc | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, parallel study to investigate the efficacy and safety of multiple oral doses of tasimelteon and matching placebo in travelers with Jet L... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005525-39 | Sponsor Protocol Number: CCR4449 | Start Date*: 2016-05-19 |
Sponsor Name:The Royal Marsden NHS Foundation Trust | ||
Full Title: Proof-of-concept study of ibrutinib in c-MYC and HER2 amplified gastrooesophageal carcinoma | ||
Medical condition: Her2 or cMYC positive advanced oesophagogastric carcinomas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003720-32 | Sponsor Protocol Number: SPECTRE2015 | Start Date*: 2016-06-01 | |||||||||||
Sponsor Name:NHS Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: Combined Suppression Of Cholesterol Bioavailability And Androgen Deprivation Therapy To Treat Castration Resistant Prostate Cancer | |||||||||||||
Medical condition: Castration Resistant Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003217-20 | Sponsor Protocol Number: 15073 | Start Date*: 2016-03-23 |
Sponsor Name:University of Nottingham | ||
Full Title: Management of recurrent pterygium to prevent visual impairment(REPEAT) | ||
Medical condition: RECURRENT PTERYGIUM | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.